| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
0 |
| Employees |
17 |
| Revenues (TTM) (Millions $) |
1 |
| Net Income (TTM) (Millions $) |
-32 |
| Cash Flow (TTM) (Millions $) |
-9 |
| Capital Exp. (TTM) (Millions $) |
0 |
Biora Therapeutics Inc
Biora Therapeutics Inc is a biotechnology company that specializes in developing innovative solutions for the treatment of chronic wounds. The company was founded in 1994 and is based in Malmo, Sweden. It has a global presence with offices in Europe, North America, and Asia.
The main focus of Biora Therapeutics is to develop bioactive materials that can stimulate and enhance the natural healing process of chronic wounds. These materials are designed to work in synergy with the body's own immune system and promote tissue repair and regeneration.
The company has developed several proprietary technologies that are based on the use of growth factors, collagen matrices, and other biomaterials. These technologies are designed to deliver an optimized combination of growth factors and other bioactive molecules to chronic wounds, thereby promoting faster healing and reducing the risk of infection.
Biora Therapeutics has a range of products that are used in the treatment of chronic wounds, including diabetic foot ulcers, venous ulcers, pressure ulcers, and burn injuries. The company's flagship product is Purion, a patented collagen matrix that contains a specific combination of growth factors and antimicrobial peptides. Purion is designed to stimulate wound healing while also reducing the risk of infection.
In addition to Purion, Biora Therapeutics has also developed a range of other products, including wound dressings, wound care kits, and topical gels. These products are aimed at meeting the needs of patients across a wide range of wound types and severities.
The company has a strong commitment to research and development, and invests heavily in innovative technologies and new therapeutic approaches. Biora Therapeutics works closely with leading academic and clinical research institutions to gather evidence-based data on the efficacy and safety of its products.
Overall, Biora Therapeutics is a leading innovator in the field of wound care, and its products have been shown to deliver significant benefits to patients with chronic wounds. With its strong focus on research and development, the company is well positioned to continue driving advances in this important area of healthcare.
Company Address: 4330 La Jolla Village Drive San Diego 92122 CA
Company Phone Number: 727-2841 Stock Exchange / Ticker: NASDAQ BIOR
|
0.000%
3.11% 